Additionally, Cannabinoid receptor 2 (CNR2), a cannabinoid receptor, disrupts CD8+ T and NK cell activity in the TME [29] and promotes tumor growth through the p38 MAPK pathway, making it a notable marker for HPV-positive HNSCC [30]. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.